The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection.
Conferences
Hoffmann, SC; Kampen, RL; Pearl, JP; Hale, DA; Jacobson, LM; Kleiner, DE; Mannon, RB; Muehrer, RJ; Swanson, SJ; Becker, BN; Kirk, AD
Published in: AMERICAN JOURNAL OF TRANSPLANTATION
January 1, 2004
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
ISSN
1600-6135
Publication Date
January 1, 2004
Volume
4
Start / End Page
332 / 332
Location
Boston, MA
Publisher
BLACKWELL MUNKSGAARD
Conference Name
American Transplant Congress
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hoffmann, S. C., Kampen, R. L., Pearl, J. P., Hale, D. A., Jacobson, L. M., Kleiner, D. E., … Kirk, A. D. (2004). The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 4, pp. 332–332). Boston, MA: BLACKWELL MUNKSGAARD.
Hoffmann, S. C., R. L. Kampen, J. P. Pearl, D. A. Hale, L. M. Jacobson, D. E. Kleiner, R. B. Mannon, et al. “The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection.” In AMERICAN JOURNAL OF TRANSPLANTATION, 4:332–332. BLACKWELL MUNKSGAARD, 2004.
Hoffmann SC, Kampen RL, Pearl JP, Hale DA, Jacobson LM, Kleiner DE, et al. The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection. In: AMERICAN JOURNAL OF TRANSPLANTATION. BLACKWELL MUNKSGAARD; 2004. p. 332–332.
Hoffmann, S. C., et al. “The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 4, BLACKWELL MUNKSGAARD, 2004, pp. 332–332.
Hoffmann SC, Kampen RL, Pearl JP, Hale DA, Jacobson LM, Kleiner DE, Mannon RB, Muehrer RJ, Swanson SJ, Becker BN, Kirk AD. The new standard of care: Alemtuzumab induction with Tacrolimus and Sirolimus maintenance immunosuppression to limit acute and chronic allograft rejection. AMERICAN JOURNAL OF TRANSPLANTATION. BLACKWELL MUNKSGAARD; 2004. p. 332–332.
Published In
AMERICAN JOURNAL OF TRANSPLANTATION
ISSN
1600-6135
Publication Date
January 1, 2004
Volume
4
Start / End Page
332 / 332
Location
Boston, MA
Publisher
BLACKWELL MUNKSGAARD
Conference Name
American Transplant Congress
Related Subject Headings
- Surgery
- 3204 Immunology
- 3202 Clinical sciences